Germany Cancer Supportive Care Drugs Market
The Germany cancer supportive care drugs market is restrained by high expenditure of supportive care drugs, stringent regulatory approval procedures, and safety concerns. In addition, the risk of side effects, the availability of general options, and the reimbursement limit are factors with market expansion.